Mechanically, lower expression of FABP4 significantly increased CD80+CCR7+ macrophages (pro‐inflammatory subtype), along with decreased CD209+CD36+ anti‐inflammatory phenotype, which provides a validated explanation for decreased FABP4 expression in inhibiting NB growth via TAMs. The gene discussed is CD80; the disease is neuroblastoma.